Allergy

ANN & ROBERT H. LURIE CHILDREN'S HOSPITAL OF CHICAGO

FOOD ALLERGY RESEARCH

Contact: 312.227.6153 or allergystudy@luriechildrens.org  

 

Horizontal FA display 

  


  

 WHAT'S NEW IN FOOD ALLERGY RESEARCH AT LURIE CHILDREN'S:  

 

    PRROTECT Peanut Allergy Clinical Trial:  

Ann & Robert H. Lurie Children’s Hospital of Chicago is conducting a study for peanut allergic volunteers 7-24 years old called The PRROTECT (Peanut Reactivity Reduced by Oral Tolerance in an anti-IgE Clinical Trial) Study. This study is researching a potential treatment for peanut allergy using Xolair and oral immunotherapy, which together are intended to quickly alter the immune system’s response to food allergens. The study lasts about 1 year, and participants will come to Lurie Children’s for study visits, get regular injections of Xolair, and ingest peanut at home every day in slowly increasing amounts.  

The goal of the study is to allow patients who are peanut allergic to safely eat peanut and improve their allergic symptoms. The study is designed to determine whether Xolair helps peanut allergic patients become desensitized (short-term protection from reactions to peanut) quickly, and to assess the safety risks of this treatment. All study-related visits and laboratory tests are provided at no cost, and compensation is provided. To receive more information, contact 312.227.6153 or allergystudy@luriechildrens.org. 

View study brochure HERE  

This study is IRB #2013-15326, Jacqueline Pongracic, MD, Principal Investigator. The content of this notice have been approved by the Lurie Children’s IRB. 


      Wheat Oral Immunotherapy Clinical Trial:   

Ann & Robert H. Lurie Children’s Hospital of Chicago is conducting a new clinical trial for wheat allergic volunteers ages 4-24 years old. This study is researching a potential treatment for wheat allergy called oral immunotherapy (OIT), which is designed to alter the immune system’s response to food allergens. Participants will ingest a specific wheat product in slowly increasing amounts every day for up to two years. The study is designed to determine whether OIT can effectively cause wheat desensitization (short-term protection from reactions to wheat) and/or ultimately induce tolerance (long lasting protection), and to assess the safety risks of this treatment. All study-related visits and laboratory tests are provided at no cost, and compensation is provided. To receive more information, contact 312.227.6153 or allergystudy@luriechildrens.org. 

View study brochure HERE 

This study is IRB #2012-15112, Jacqueline Pongracic, MD, Principal Investigator. The content of this notice have been approved by the Lurie Children’s IRB  


     Viaskin® Peanut Clinical Trial (VIPES):    

Ann & Robert H. Lurie Children’s Hospital of Chicago is currently conducting a new clinical trial for peanut allergic volunteers ages 6-24 years old. This study is researching a potential immunotherapy treatment for peanut allergy called Viaskin® Peanut, which is a patch that contains peanut proteins and is placed on the skin. The trial lasts 58 weeks and is designed to determine whether Viaskin® Peanut can effectively reduce sensitivity to peanuts, and to assess the safety risks of this treatment. All study-related visits and laboratory tests are provided at no cost, and some compensation is provided for time and travel. To receive more information, contact 312.227.6153 or allergystudy@luriechildrens.org. 

View study brochure HERE 

Enrollment is currently closed for this study.  

 This study is IRB #2012-14890 , Jacqueline Pongracic, MD, Principal Investigator. The content of this notice have been approved by the Lurie Children’s IRB   


 

     FAHF-2 Clinical Trial:   

 Ann & Robert H. Lurie Children's Hospital of Chicago is currently conducting a clinical trial involving Chinese Herbal Medicine for the treatment of food allergy for volunteers 12-24 years old.  The trial will determine the effectiveness of Chinese Herbs, in pill form, as a treatment for peanut, tree nuts, sesame, fish, or shellfish allergies. All study-related visits and laboratory tests are provided at no cost.   

This clinical trial is supported by the National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health (NIH) and Food Allergy Initiative. To receive more information, contact 312.227.6153 or allergystudy@luriechildrens.org.   

View study brochure HERE 

Enrollment is currently closed for this study. 

 This study is CMH IRB # 2011-14582, Jacqueline Pongracic, MD, Principal Investigator. The content of this notice has been approved by the CMH IRB.    


 

Food Allergy Study:    

Enrollment for the Food Allergy Study at Children's Memorial Hospital is now closed and no more appointments for families are being scheduled. Our current food allergy research studies are posted on this web page, or you can contact 312.227.6153 or allergystudy@luriechildrens.org for more information.  

Enrollment is currently closed for this study.  

 

 

 


    Lurie Children’s is dedicated to providing excellent medical care as well as conducting research that will benefit the lives of children